tiprankstipranks
Trending News
More News >
Impedimed Limited (AU:IPD)
:IPD
Australian Market

Impedimed Limited (IPD) Technical Analysis

Compare
21 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
1Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Impedimed Limited’s (IPD) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Impedimed Limited is a Sell.
Impedimed Limited’s (IPD) 20-Day exponential moving average is 0.03, while Impedimed Limited’s (IPD) share price is <AU$0.1, making it a Buy.
Impedimed Limited’s (IPD) 50-Day exponential moving average is 0.04, while Impedimed Limited’s (IPD) share price is <AU$0.1, making it a Sell.

Impedimed Limited (IPD) Pivot Points

Jun 11, 2025, 05:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.03
0.03
0.03
0.03
0.04
Fibonacci
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Impedimed Limited (IPD) Moving Averages

Jun 11, 2025, 05:26 AM
Period
Simple
Exponential
MA5
0.03Buy
0.03Buy
MA10
0.03Buy
0.03Buy
MA20
0.03Buy
0.03Buy
MA50
0.04Sell
0.04Sell
MA100
0.04Sell
0.04Sell
MA200
0.05Sell
0.05Sell
Impedimed Limited’s (IPD) 10-Day exponential moving average is 0.03, while Impedimed Limited’s (IPD) share price is <AU$0.1, making it a Buy.
Impedimed Limited’s (IPD) 100-Day exponential moving average is 0.04, while Impedimed Limited’s (IPD) share price is <AU$0.1, making it a Sell.
Impedimed Limited’s (IPD) stock price is <AU$0.1 and Impedimed Limited’s (IPD) 50-day simple moving average is 0.04, creating a Sell signal.
Impedimed Limited’s (IPD) stock price is <AU$0.1 and Impedimed Limited’s (IPD) 100-day simple moving average is 0.04, creating a Sell signal.
Impedimed Limited’s (IPD) stock price is <AU$0.1 and Impedimed Limited’s (IPD) 200-day simple moving average is 0.05, creating a Sell signal.

Impedimed Limited (IPD) Technical Indicators

Jun 11, 2025, 05:26 AM
Name
Value
Implied Action
RSI (14)
52.36
Neutral
STOCH (9,6)
94.44
Sell
STOCHRSI (14)
94.44
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
13.78
Buy
Williams %R
0.00
Sell
CCI (14)
114.32
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
71.34
Buy
ROC
0.00
Buy
Impedimed Limited’s (IPD) Relative Strength Index (RSI) is 52.36, creating a Neutral signal.
Impedimed Limited’s (IPD) Trend Strength Indicator (ADX) is 13.78, creating a Buy signal.
Impedimed Limited’s (IPD) Commodity Channel Index (CCI) is 114.32, creating a Sell signal.

FAQ

Is IPD a Buy, Hold, or Sell?
Based on IPD’s technical indicators, IPD is a Hold.
    What is IPD’s RSI (14)?
    IPD’s RSI (14) is 52.36, which suggests IPD is a Neutral.
      What is IPD’s MACD?
      IPD’s MACD is >-0.01, which suggests IPD is a Sell.
        What is IPD’s 5-day moving average?
        IPD’s 5-day moving average is 0.03, which suggests IPD is a Buy.
          What is IPD’s 20-day moving average?
          IPD 20-day moving average is 0.03, which suggests IPD is a Buy.
            What is IPD’s 50-day moving average?
            IPD’s 50-day moving average is 0.04, which suggests IPD is a Sell.
              What is IPD’s 200-day moving average?
              IPD’s 200-day moving average is 0.05, which suggests IPD is a Sell.
                What is IPD’s Williams % R (14)?
                IPD’s Williams % R (14) is 0.00, which suggests IPD is a Sell.
                  What is IPD’s CCI (14)?
                  IPD’s CCI (14) is 114.32, which suggests IPD is a Sell.
                    What is the share price of Impedimed Limited?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis